Literature DB >> 20225011

VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Michael D Gershon1, Anne A Gershon.   

Abstract

Varicella-zoster virus (VZV) is the cause of varicella (chickenpox) and zoster (shingles). Varicella is a primary infection that spreads rapidly in epidemics while zoster is a secondary infection that occurs sporadically as a result of the reactivation of previously acquired VZV. Reactivation is made possible by the establishment of latency during the initial episode of varicella. The signature lesions of both varicella and zoster are cutaneous vesicles, which are filled with a clear fluid that is rich in infectious viral particles. It has been postulated that the skin is the critical organ in which both host-to-host transmission of VZV and the infection of neurons to establish latency occur. This hypothesis is built on evidence that the large cation-independent mannose 6-phosphate receptor (MPR(ci)) interacts with VZV in virtually all infected cells, except those of the suprabasal epidermis, in a way that prevents the release of infectious viral particles. Specifically, the virus is diverted in an MPR(ci)-dependent manner from the secretory pathway to late endosomes where VZV is degraded. Because nonepidermal cells are thus prevented from releasing infectious VZV, a slow process, possibly involving fusion of infected cells with their neighbors, becomes the means by which VZV is disseminated. In the epidermis, however, the maturation of keratinocytes to give rise to corneocytes in the suprabasal epidermis is associated uniquely with a downregulation of the MPR(ci). As a result, the diversion of VZV to late endosomes does not occur in the suprabasal epidermis where vesicular lesions occur. The formation of the waterproof, chemically resistant barrier of the epidermis, however, requires that constitutive secretion outlast the downregulation of the endosomal pathway. Infectious VZV is therefore secreted by default, accounting for the presence of infectious virions in vesicular fluid. Sloughing of corneocytes, aided by scratching, then aerosolizes the virus, which can float with dust to be inhaled by susceptible hosts. Infectious virions also bathe the terminals of those sensory neurons that innervate the epidermis. These terminals become infected with VZV and provide a route, retrograde transport, which can conduct VZV to cranial nerve (CNG), dorsal root ganglia (DRG), and enteric ganglia (EG) to establish latency. Reactivation returns VZV to the skin, now via anterograde transport in axons, to cause the lesions of zoster. Evidence in support of these hypotheses includes observations of the VZV-infected human epidermis and studies of guinea pig neurons in an in vitro model system.

Entities:  

Mesh:

Year:  2010        PMID: 20225011      PMCID: PMC5408736          DOI: 10.1007/82_2010_13

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  79 in total

1.  Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; S Bontems; C Sadzot-Delvaux
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

2.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Herpes zoster post-herpetic neuralgia.

Authors:  L Feller; Y Jadwat; M Bouckaert
Journal:  SADJ       Date:  2005-11

4.  T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection.

Authors:  Anne Schaap; Jean-Francois Fortin; Marvin Sommer; Leigh Zerboni; Shaye Stamatis; Chia-Chi Ku; Garry P Nolan; Ann M Arvin
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Localization of the signal for rapid internalization of the bovine cation-independent mannose 6-phosphate/insulin-like growth factor-II receptor to amino acids 24-29 of the cytoplasmic tail.

Authors:  W M Canfield; K F Johnson; R D Ye; W Gregory; S Kornfeld
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

6.  Evidence of airborne transmission of the severe acute respiratory syndrome virus.

Authors:  Ignatius T S Yu; Yuguo Li; Tze Wai Wong; Wilson Tam; Andy T Chan; Joseph H W Lee; Dennis Y C Leung; Tommy Ho
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

7.  A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.

Authors:  Anne A Gershon; Jason Chen; Michael D Gershon
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

8.  Congenital varicella syndrome: still a problem?

Authors:  Cinzia Auriti; Fiammetta Piersigilli; Marco Rossi De Gasperis; Giulio Seganti
Journal:  Fetal Diagn Ther       Date:  2009-05-27       Impact factor: 2.587

Review 9.  Making an epidermis.

Authors:  Maranke I Koster
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

10.  Intracellular movement of two mannose 6-phosphate receptors: return to the Golgi apparatus.

Authors:  J R Duncan; S Kornfeld
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  15 in total

1.  The Herpesviridae Conserved Multifunctional Infected-Cell Protein 27 (ICP27) Is Important but Not Required for Replication and Oncogenicity of Marek's Disease Alphaherpesvirus.

Authors:  Nagendraprabhu Ponnuraj; Yung-Tien Tien; Widaliz Vega-Rodriguez; Andrea Krieter; Keith W Jarosinski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Role for the αV Integrin Subunit in Varicella-Zoster Virus-Mediated Fusion and Infection.

Authors:  Edward Yang; Ann M Arvin; Stefan L Oliver
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

3.  The C-terminus of varicella-zoster virus glycoprotein M contains trafficking motifs that mediate skin virulence in the SCID-human model of VZV pathogenesis.

Authors:  Leigh Zerboni; Phillip Sung; Marvin Sommer; Ann Arvin
Journal:  Virology       Date:  2018-08-14       Impact factor: 3.616

4.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

Review 5.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

6.  Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.

Authors:  Leigh Zerboni; Phillip Sung; Gordon Lee; Ann Arvin
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Varicella-zoster virus infects human embryonic stem cell-derived neurons and neurospheres but not pluripotent embryonic stem cells or early progenitors.

Authors:  Anna Dukhovny; Anna Sloutskin; Amos Markus; Michael B Yee; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

Review 8.  Varicella zoster virus vaccines: potential complications and possible improvements.

Authors:  Benjamin Silver; Hua Zhu
Journal:  Virol Sin       Date:  2014-10-24       Impact factor: 4.327

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

10.  A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.

Authors:  Megan G Lloyd; Nicholas A Smith; Michael Tighe; Kelsey L Travis; Dongmei Liu; Prashant K Upadhyaya; Paul R Kinchington; Gary C Chan; Jennifer F Moffat
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.